TUBA1B and hepatocellular carcinoma: Although research on TUBA1B’s role in human cancers is limited, some studies have linked it to poor prognosis and chemotherapy resistance in hepatocellular carcinoma (Lu et al., 2013) and disease progression in Wilms’ tumor (Xu et al., 2020).